205 related articles for article (PubMed ID: 24260386)
1. β-Globin sleeping beauty transposon reduces red blood cell sickling in a patient-derived CD34(+)-based in vitro model.
Sjeklocha LM; Wong PY; Belcher JD; Vercellotti GM; Steer CJ
PLoS One; 2013; 8(11):e80403. PubMed ID: 24260386
[TBL] [Abstract][Full Text] [Related]
2. Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cells.
Urbinati F; Hargrove PW; Geiger S; Romero Z; Wherley J; Kaufman ML; Hollis RP; Chambers CB; Persons DA; Kohn DB; Wilber A
Exp Hematol; 2015 May; 43(5):346-351. PubMed ID: 25681747
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic hemoglobin levels after gene transfer in β-thalassemia mice and in hematopoietic cells of β-thalassemia and sickle cells disease patients.
Breda L; Casu C; Gardenghi S; Bianchi N; Cartegni L; Narla M; Yazdanbakhsh K; Musso M; Manwani D; Little J; Gardner LB; Kleinert DA; Prus E; Fibach E; Grady RW; Giardina PJ; Gambari R; Rivella S
PLoS One; 2012; 7(3):e32345. PubMed ID: 22479321
[TBL] [Abstract][Full Text] [Related]
4. Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison Study.
Urbinati F; Campo Fernandez B; Masiuk KE; Poletti V; Hollis RP; Koziol C; Kaufman ML; Brown D; Mavilio F; Kohn DB
Hum Gene Ther; 2018 Oct; 29(10):1153-1166. PubMed ID: 30198339
[TBL] [Abstract][Full Text] [Related]
5. Erythroid-specific expression of β-globin from Sleeping Beauty-transduced human hematopoietic progenitor cells.
Sjeklocha LM; Park CW; Wong PY; Roney MJ; Belcher JD; Kaufman DS; Vercellotti GM; Hebbel RP; Steer CJ
PLoS One; 2011; 6(12):e29110. PubMed ID: 22216176
[TBL] [Abstract][Full Text] [Related]
6. Correction of sickle cell disease in transgenic mouse models by gene therapy.
Pawliuk R; Westerman KA; Fabry ME; Payen E; Tighe R; Bouhassira EE; Acharya SA; Ellis J; London IM; Eaves CJ; Humphries RK; Beuzard Y; Nagel RL; Leboulch P
Science; 2001 Dec; 294(5550):2368-71. PubMed ID: 11743206
[TBL] [Abstract][Full Text] [Related]
7. Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease.
Park SH; Lee CM; Dever DP; Davis TH; Camarena J; Srifa W; Zhang Y; Paikari A; Chang AK; Porteus MH; Sheehan VA; Bao G
Nucleic Acids Res; 2019 Sep; 47(15):7955-7972. PubMed ID: 31147717
[TBL] [Abstract][Full Text] [Related]
8. The genetic basis and evolution of red blood cell sickling in deer.
Esin A; Bergendahl LT; Savolainen V; Marsh JA; Warnecke T
Nat Ecol Evol; 2018 Feb; 2(2):367-376. PubMed ID: 29255300
[TBL] [Abstract][Full Text] [Related]
9. Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene.
Negre O; Eggimann AV; Beuzard Y; Ribeil JA; Bourget P; Borwornpinyo S; Hongeng S; Hacein-Bey S; Cavazzana M; Leboulch P; Payen E
Hum Gene Ther; 2016 Feb; 27(2):148-65. PubMed ID: 26886832
[TBL] [Abstract][Full Text] [Related]
10. Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing.
Wen J; Tao W; Hao S; Zu Y
J Hematol Oncol; 2017 Jun; 10(1):119. PubMed ID: 28610635
[TBL] [Abstract][Full Text] [Related]
11. Base editing of haematopoietic stem cells rescues sickle cell disease in mice.
Newby GA; Yen JS; Woodard KJ; Mayuranathan T; Lazzarotto CR; Li Y; Sheppard-Tillman H; Porter SN; Yao Y; Mayberry K; Everette KA; Jang Y; Podracky CJ; Thaman E; Lechauve C; Sharma A; Henderson JM; Richter MF; Zhao KT; Miller SM; Wang T; Koblan LW; McCaffrey AP; Tisdale JF; Kalfa TA; Pruett-Miller SM; Tsai SQ; Weiss MJ; Liu DR
Nature; 2021 Jul; 595(7866):295-302. PubMed ID: 34079130
[TBL] [Abstract][Full Text] [Related]
12. Combination of lentiviral and genome editing technologies for the treatment of sickle cell disease.
Ramadier S; Chalumeau A; Felix T; Othman N; Aknoun S; Casini A; Maule G; Masson C; De Cian A; Frati G; Brusson M; Concordet JP; Cavazzana M; Cereseto A; El Nemer W; Amendola M; Wattellier B; Meneghini V; Miccio A
Mol Ther; 2022 Jan; 30(1):145-163. PubMed ID: 34418541
[TBL] [Abstract][Full Text] [Related]
13. Insight into the complex pathophysiology of sickle cell anaemia and possible treatment.
Piccin A; Murphy C; Eakins E; Rondinelli MB; Daves M; Vecchiato C; Wolf D; Mc Mahon C; Smith OP
Eur J Haematol; 2019 Apr; 102(4):319-330. PubMed ID: 30664257
[TBL] [Abstract][Full Text] [Related]
14. βT87Q-Globin Gene Therapy Reduces Sickle Hemoglobin Production, Allowing for
Demirci S; Gudmundsdottir B; Li Q; Haro-Mora JJ; Nassehi T; Drysdale C; Yapundich M; Gamer J; Seifuddin F; Tisdale JF; Uchida N
Mol Ther Methods Clin Dev; 2020 Jun; 17():912-921. PubMed ID: 32405513
[TBL] [Abstract][Full Text] [Related]
15. Erythroid-specific expression of beta-globin by the sleeping beauty transposon for Sickle cell disease.
Zhu J; Kren BT; Park CW; Bilgim R; Wong PY; Steer CJ
Biochemistry; 2007 Jun; 46(23):6844-58. PubMed ID: 17508724
[TBL] [Abstract][Full Text] [Related]
16. LIN28A expression reduces sickling of cultured human erythrocytes.
de Vasconcellos JF; Fasano RM; Lee YT; Kaushal M; Byrnes C; Meier ER; Anderson M; Rabel A; Braylan R; Stroncek DF; Miller JL
PLoS One; 2014; 9(9):e106924. PubMed ID: 25188417
[TBL] [Abstract][Full Text] [Related]
17. Development of a forward-oriented therapeutic lentiviral vector for hemoglobin disorders.
Uchida N; Hsieh MM; Raines L; Haro-Mora JJ; Demirci S; Bonifacino AC; Krouse AE; Metzger ME; Donahue RE; Tisdale JF
Nat Commun; 2019 Oct; 10(1):4479. PubMed ID: 31578323
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation for engraftment of CD34
Uchida N; Li L; Nassehi T; Drysdale CM; Yapundich M; Gamer J; Haro-Mora JJ; Demirci S; Leonard A; Bonifacino AC; Krouse AE; Linde NS; Allen C; Peshwa MV; De Ravin SS; Donahue RE; Malech HL; Tisdale JF
Cell Rep Med; 2021 Apr; 2(4):100247. PubMed ID: 33948577
[TBL] [Abstract][Full Text] [Related]
19. In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse.
Kaul DK; Fabry ME; Costantini F; Rubin EM; Nagel RL
J Clin Invest; 1995 Dec; 96(6):2845-53. PubMed ID: 8675655
[TBL] [Abstract][Full Text] [Related]
20. Kruppel-like factor 1-GATA1 fusion protein improves the sickle cell disease phenotype in mice both in vitro and in vivo.
Zhu J; Li H; Aerbajinai W; Kumkhaek C; Pirooznia M; Saxena A; Dagur P; Chin K; Rodgers GP
Blood; 2022 Nov; 140(21):2276-2289. PubMed ID: 36399071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
